...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Successful intravenous Alteplase for a centenarian woman with acute ischaemic stroke
【24h】

Successful intravenous Alteplase for a centenarian woman with acute ischaemic stroke

机译:成功的静脉内普拉酶为急性缺血性卒中的百年生女性

获取原文
获取原文并翻译 | 示例

摘要

Summary We report a case of a 105‐year‐old woman who was treated with Alteplase for acute ischaemic stroke ( AIS ). On arrival, this centenarian woman had sudden‐onset aphasia and right‐sided hemiparesis, her baseline National Institutes of Health Stroke Scale ( NIHSS ) score was 21. An acute noncontrast brain CT scan showed only mild white matter disease. After assessing the patient's risk‐benefit ratio, the patient was administered intravenous Alteplase (0.9?mg/kg) 2.5?hours after symptom onset. Her right hemiparesis and aphasia eased within 24?hours after Alteplase treatment. At discharge, her NIHSS score had decreased to 1, leaving only mild right facial palsy unresolved. Few clinical data are available on centenarian patients with AIS who undergo intravenous thrombolysis. There are no data on what is the best method to use to manage centenarians. Our successful thrombolysis case indicates that biologically young centenarians may profit from thrombolysis, despite the very high age.
机译:总结我们举报了一个105岁女性的案例,该女性被Alteplase治疗急性缺血性卒中(AIS)。在抵达时,这位百年生女性突然发病了,她的基线国家卫生卒中量表(NIHSS)得分为21.急性非致力脑CT扫描显示轻度白质疾病。在评估患者的风险效益比后,患者静脉内普通普(0.9≤mg/ kg)2.5?症状发作后的疗效。她的右偏瘫和失语症在24℃下缓解了整形酶治疗后的时间。在出院时,她的NIHSS得分减少到1,只留下了温和的右面部麻痹未解决。在终身溶栓的AIS患者上有很少的临床资料,患有静脉溶栓。没有关于管理百岁老人的最佳方法的数据。我们成功的溶栓案例表明,尽管年龄很高,但生物学上年轻的百岁脑可能会从溶栓中获利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号